Public-health information · Research, risks, and help

Blog

Source-led 7-OH articles on product differences, dependence, withdrawal, and getting appropriate help.

Updated

1 sources
Organized guide cards connected by simple paths.
Kratom leaf, concentrated 7-OH, dependence, and treatment resources are connected topics in this collection.

Direct answer

These articles focus on concentrated 7-OH, product identity, and difficulty stopping. FDA's clinician letter explains why withdrawal and breathing risks deserve attention. FDA letter to health care professionals

Articles

Related reading

For the study evidence, read Science and Evidence. For dated legal developments, read the Regulatory Tracker. For emergency or referral support, see Get Help.

Sources

  1. FDA letter to health care professionals

Related reading

What Is 7-OH?7-OH explained: 7-hydroxymitragynine, concentrated product forms, potency evidence, and regulatory concern.Signs of Dependence and Withdrawal7-OH dependence and withdrawal: warning signs, symptoms, and when to talk to a clinician, with context on kratom leaf.Guides7-OH guides for families, clinicians, journalists, and people evaluating concentrated products or kratom leaf.Science and Evidence7-OH science: receptor pharmacology, withdrawal evidence, FDA materials, and limits in the evidence base.